VIRIDIAN THERAPEUTICS INC

25 de set. de 2026, 20:07 UTC

Viridian Therapeutics Inc shares fell sharply, closing lower for the third consecutive session and remaining significantly below the 20-day moving average.

24 de set. de 2026, 20:07 UTC

Viridian Therapeutics Inc shares fell sharply, finishing significantly lower than Wednesday's close and well below its 20-day moving average.

23 de set. de 2026, 20:12 UTC

Viridian Therapeutics Inc saw modestly lower trading in after-market hours on Wednesday, remaining significantly below its 20-day moving average.

22 de set. de 2026, 19:34 UTC

RBC Capital raised its price target on Viridian Therapeutics to $38, maintaining an Outperform rating, as the stock holds gains above Monday's close despite earlier pulling back.

21 de set. de 2026, 20:12 UTC

Viridian Therapeutics Inc is trading modestly higher in after-market hours, maintaining stability with no significant movement since Monday's close.

17 de set. de 2026, 19:46 UTC

Viridian Therapeutics Inc shares fell sharply as the company navigates post-FDA approval dynamics for Lumvoa, remaining below its 20-day moving average.

16 de set. de 2026, 22:01 UTC

Viridian Therapeutics Inc is rising in after-market trading, moving from a low of 1.02% to a high of 1.20% since Wednesday's close.

15 de set. de 2026, 19:36 UTC

Viridian Therapeutics shares are lower today, continuing a decline since Monday amid broader market pressure from rising treasury yields. No specific news was identified.

14 de set. de 2026, 20:13 UTC

Viridian Therapeutics Inc. shares are higher in after-market hours, maintaining a cumulative return since Monday's close, despite a weaker performance backdrop.

11 de set. de 2026, 23:26 UTC

Viridian Therapeutics Inc shares are lower in after-market trading, with no specific news identified to explain the decline. Recent U.S. inflation data adds broader context.

10 de set. de 2026, 20:13 UTC

Viridian Therapeutics Inc. shares are higher in after-market trading, though they remain below the 20-day moving average and near the lower end of their one-month range.

9 de set. de 2026, 21:02 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, declining from an initial drop to a more pronounced decrease amid weak trading.

8 de set. de 2026, 20:13 UTC

Viridian Therapeutics Inc shares are higher in after-market trading. No specific news was identified to explain the price movement.

3 de set. de 2026, 19:16 UTC

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026. Shares are slightly higher during Thursday's session.

2 de set. de 2026, 22:06 UTC

Viridian Therapeutics will participate in the Wells Fargo Healthcare Conference on September 8, 2026, with a fireside chat accessible via a live webcast. Shares are little changed.

28 de ago. de 2026, 20:02 UTC

Viridian Therapeutics Inc shares are lower today, breaking a trend of higher closes. Broader market pressures from rising U.S. Treasury yields may be influencing this decline.

27 de ago. de 2026, 22:01 UTC

Viridian Therapeutics Inc shares are lower in after-market hours, reflecting notable weakness following a flat start to the session. No specific news was identified.

25 de ago. de 2026, 20:07 UTC

Viridian Therapeutics is gaining amid a broader positive market trend, despite earlier pulling back from a session high. Shares remain above the 20-day moving average.

24 de ago. de 2026, 19:26 UTC

Viridian Therapeutics Inc is declining during Monday's session, continuing a trend of lower performance over the past three days amid geopolitical and inflation concerns.

21 de ago. de 2026, 23:21 UTC

Viridian Therapeutics Inc. shares advanced in after-market trading, continuing a strong one-month performance and remaining above the 20-day moving average.

20 de ago. de 2026, 22:56 UTC

Viridian Therapeutics Inc. shares declined in after-hours trading, reflecting broader market trends amid concerns about consumer spending and inflation pressures.

19 de ago. de 2026, 23:01 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, reflecting positive market sentiment amid broader gains and strong performance in cryptocurrency values.

17 de ago. de 2026, 20:06 UTC

Viridian Therapeutics Inc shares rose significantly since Friday's close, reaching a peak increase in late morning trading, though no specific news was identified.

14 de ago. de 2026, 19:56 UTC

Viridian Therapeutics is trading higher, recovering from an earlier dip, as broader market sentiment reacts to a surprise decline in U.S. retail sales.

13 de ago. de 2026, 19:56 UTC

Viridian Therapeutics Inc shares declined again, marking five consecutive lower closes, amid broader weakness in the biotechnology sector and rising unemployment claims.

11 de ago. de 2026, 19:46 UTC

Viridian Therapeutics Inc shares are lower today amid broader market declines following a weak jobs report, influencing expectations for Federal Reserve policy.

7 de ago. de 2026, 20:05 UTC

Viridian Therapeutics shares rise after Truist Securities raised its price target to $39. The ARK Genomic Revolution ETF's gains may also influence the stock.

6 de ago. de 2026, 21:02 UTC

Viridian Therapeutics Inc is trading higher in after-market hours, extending five consecutive sessions of gains amid broader market resilience and positive economic data.

5 de ago. de 2026, 23:02 UTC

Viridian Therapeutics Inc shares declined in after-market trading, sharply lower since Wednesday's close, despite finishing higher in the previous three sessions.

4 de ago. de 2026, 21:02 UTC

Viridian Therapeutics shares are lower in after-hours trading, declining from earlier session highs despite being above the 20-day moving average.